Instrument Calibration
ANSTO offers reliable and traceable calibration services for radiation survey meters, contamination monitors and electronic personal dosimeters.
Showing 641 - 660 of 982 results
ANSTO offers reliable and traceable calibration services for radiation survey meters, contamination monitors and electronic personal dosimeters.
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Don't miss latest nuclear science and technology news from ANSTO.
ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods.
ANSTO researchers have demonstrated longstanding expertise in the study of nuclear fuel and radioactive waste with two recent journal articles in a special issue of Frontiers of Chemistry.
ANSTO is proud to host the Shorebirds Competition for the fifth year. This unique environmental poster competition is free to enter and offers over $4500 in prizes for students and schools!
ANSTO has produced a comprehensive report for the NSW Department of Planning and Environment that represents a significant scientific investigation of the connections, pathways and processes of water loss from the Thirlmere Lakes system.
An investigation that set out to resolve some of the uncertainty in the sources and quantities of pollutants reaching Antarctica has produced a new experimental technique to identify and characterise recently terrestrially-influenced air reaching Antarctica.
ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.
Read about an ANSTO scientist and their work to prepare for a school project or interview.
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.